Merck Sharp & Dohme Corp. 3
3 · Menlo Therapeutics, Inc. · Filed Jan 24, 2018
Insider Transaction Report
Form 3
Merck & Co., Inc.
10% Owner
Holdings
- 1,243,168(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]These securities are owned directly by Merck Sharp & Dohme Corp., which is a direct, wholly owned subsidiary of Merck & Co., Inc. ("Merck"). Merck is an indirect beneficial owner of the reported securities.